Renaissance Technologies’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.1K Buy
122,200
+87,000
+247% +$62K ﹤0.01% 2982
2026
Q1
$16.1K Sell
35,200
-1,827,851
-98% -$1.69M ﹤0.01% 3181
2025
Q4
$4.1M Buy
1,863,051
+1,086,351
+140% +$1.75M 0.01% 1417
2025
Q3
$1.23M Buy
+776,700
New +$1.01M ﹤0.01% 2376
2024
Q4
Sell
-62,695
Closed -$159K 3964
2024
Q3
$159K Buy
62,695
+48,495
+342% +$158K ﹤0.01% 3172
2024
Q2
$60.6K Buy
+14,200
New +$91.4K ﹤0.01% 3262

Other funds holding GUTS

Renaissance Technologies's GUTS Position: Q2 2026 in Review

Renaissance Technologies increased its Fractyl Health (GUTS) stake by 247% in Q2 2026, buying an estimated $62K and bringing the position to 122,200 shares worth $97.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2982.

Renaissance Technologies first reported a position in GUTS in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.1M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Renaissance Technologies held 122,200 shares of Fractyl Health worth $97.1K as of Q2 2026.
  • Renaissance Technologies bought 87,000 Fractyl Health shares in Q2 2026, an estimated $62K.
  • Fractyl Health made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2982 holding.
  • Renaissance Technologies first reported a position in Fractyl Health in Q2 2024 and has held it in 6 quarters since.
  • Renaissance Technologies's Fractyl Health position peaked at $4.1M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.